Investment analysts at StockNews.com started coverage on shares of 22nd Century Group (NASDAQ:XXII – Get Free Report) in a research note issued to investors on Thursday. The firm set a “sell” rating on the biotechnology company’s stock.
22nd Century Group Price Performance
XXII opened at $0.10 on Thursday. The stock has a market capitalization of $3.24 million, a price-to-earnings ratio of 0.00 and a beta of 1.45. The business has a fifty day moving average price of $0.20 and a 200 day moving average price of $0.69. 22nd Century Group has a 12 month low of $0.09 and a 12 month high of $7.42.
22nd Century Group (NASDAQ:XXII – Get Free Report) last announced its quarterly earnings results on Tuesday, August 13th. The biotechnology company reported ($0.36) earnings per share (EPS) for the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 275.12%. The business had revenue of $7.95 million for the quarter.
Institutional Inflows and Outflows
22nd Century Group Company Profile
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
See Also
- Five stocks we like better than 22nd Century Group
- How to Plot Fibonacci Price Inflection Levels
- What a Trump Win Looks Like for the Market Now and Into 2025
- Why Invest in High-Yield Dividend Stocks?
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- How is Compound Interest Calculated?
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.